SLC2A4 and cardiovascular disorder: Overexpression of miR-223 increases GLUT4 levels and inhibits insulin-stimulated AKT and GSK3β phosphorylation [145], while the overexpression of miR-133 decreases GLUT-4 levels [146], demonstrating their implication in IR and metabolic control in the heart and during cardiovascular disease.